Jonathan Lucas - Concepedia

Concepedia

Author

Jonathan Lucas

Fred Hutch Cancer Center

Also Known As

Eron, Joe J, J W Lucas, Jim Pickett, Jonathan C. Lucas, Jonathan Lucas, Jonathan P Lucas, Jonathan P. Lucas, Jonathan Paul Lucas, Magnus, Manya, Middelkoop, Keren

42

Publications

1.6K

Citations

16

H-Index

58

Concepts

All Affiliations

Fred Hutch Cancer Center Family Health International 360 Johns Hopkins University National Institute of Allergy and Infectious Diseases National Institutes of Health

JL

About

Jonathan Lucas is an author at Fred Hutch Cancer Center specializing in sexual health, hiv, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	165
2	Public Health	4	4	154
3	Social Sciences	3	3	64
4	African American Studies	2	2	114
5	Engineering	1	1	85

Jonathan Lucas

×

23

Publications

1.6K

Citations

16

H-Index

	Year	Citations
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement, New England Journal of Medicine	2021	773
Pre‐exposure prophylaxis initiation and adherence among Black men who have sex with men (<scp>MSM</scp>) in three US cities: results from the <scp>HPTN</scp> 073 study Darrell P. Wheeler, Sheldon D. Fields, Geetha Beauchamp, Journal of the International AIDS Society	2019	102
Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment Michele P. Andrasik, Gail Broder, Stephaun E. Wallace, PLoS ONE Health DisparitiesVaccine ConfidenceRacial StudyVaccine HesitancyRace	2021	98
Calculation of Mie derivatives R. G. Grainger, Jonathan Lucas, G. E. Thomas, Applied Optics Numerical AnalysisEngineeringMicrolocal AnalysisLight Scattering SpectroscopyRayleigh Scattering	2004	85
Race/ethnicity and the 2000 census: implications for public health E J Sondik, Jonathan Lucas, J H Madans, American Journal of Public Health	2000	77
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial Raphael J. Landovitz, Brett Hanscom, Meredith E. Clement, The Lancet HIV	2023	59
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel Ross Cranston, Javier R. Lama, Barbra A. Richardson, Clinical Infectious Diseases	2016	57
Retention Strategies and Factors Associated with Missed Visits Among Low Income Women at Increased Risk of HIV Acquisition in the US (HPTN 064) Danielle F. Haley, Jonathan Lucas, Carol E. Golin, AIDS Patient Care and STDs	2014	52
HIV incidence in a multinational cohort of men and transgender women who have sex with men in sub-Saharan Africa: Findings from HPTN 075 Theo Sandfort, Yamikani Mbilizi, Eduard J. Sanders, PLoS ONE Social SciencesSexual CommunicationContraceptionGender StudiesClinical Epidemiology	2021	32
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research Rona L. Siskind, Michele P. Andrasik, Shelly Karuna, JAIDS Journal of Acquired Immune Deficiency Syndromes	2016	31

Page 1